Articles related to COLORECTAL CANCER (CRC)

Microscopic colitis, often masked in routine diagnostic evaluations, necessitates a histological approach for accurate diagnosis. The disease’s association with specific medications underscores the need for careful patient medication reviews.

In the evolving landscape of colorectal cancer screening, recent evidence suggests a critical reevaluation of the benefits and risks of routine surveillance colonoscopies in patients over 70, emphasizing the importance of individualized patient care.

Abdominal cancer is no longer an ailment confined to older demographics, with a notable uptick in cases among younger adults. Physicians are urged to consider early screening, especially for patients with familial cancer histories, amidst growing concerns over lifestyle and environmental influences.

Explore the intersection of technology and gastroenterology with the CADEYETM AI system, enhancing adenoma detection in colonoscopies.

In this study assessing the utility of cfDNA testing in colorectal cancer screening, an 83.1% sensitivity was observed for detecting colorectal cancer, alongside an 89.6% specificity for advanced neoplasia.

Recent studies suggest a significant role of the gut microbiome in the development of colorectal cancer, particularly in early-onset cases. Understanding these microbial influences is crucial for physicians in diagnosing and treating this shifting demographic.